Accessibility Menu
 
Aoxing Pharmaceutical logo

Aoxing Pharmaceutical

(OTC) AOXG

Current Price$0.01
Market Cap$2.74M
Since IPO (2006)-100%
5 Year-48%
1 Year-10%
1 Month+80%

Aoxing Pharmaceutical Financials at a Glance

Market Cap

$2.74M

Revenue (TTM)

$19.29K

Net Income (TTM)

$15.34K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

5.91 (High)

Price

$0.01

Volume

1,500

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

AOXG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aoxing Pharmaceutical

Industry

Pharmaceuticals

CEO

David Duarte

Headquarters

Shijiazhuang, CN

AOXG Financials

Key Financial Metrics (TTM)

Gross Margin

88%

Operating Margin

-80%

Net Income Margin

-80%

Return on Equity

0%

Return on Capital

3%

Return on Assets

-12%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.74M

Shares Outstanding

381.21M

Volume

1.50K

Short Interest

0.00%

Avg. Volume

38.67K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$7.30K

EBITDA

$55.24K

Operating Cash Flow

$14.82K

Capital Expenditure

$0.00

Free Cash Flow

$14.82K

Cash & ST Invst.

N/A

Total Debt

N/A

Aoxing Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$17.21K

N/A

Gross Profit

$17.00K

N/A

Gross Margin

98.75%

N/A

Market Cap

$2.74M

N/A

Market Cap/Employee

$7.93K

N/A

Employees

346

N/A

Net Income

$11.20K

-119.7%

EBITDA

$11.20K

-119.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$79.04K

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$102.87K

N/A

Return on Assets

-12.19%

N/A

Return on Invested Capital

2.81%

N/A

Free Cash Flow

$800.00

N/A

Operating Cash Flow

$801.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VDRMViaDerma, Inc.
$0.00+0.00%
HMPQHempAmericana, Inc
$0.00+0.00%
SFLMSFLMaven Corp.
$0.00+0.00%
FFNTF4Front Ventures Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About AOXG

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.